Serum cholesterol reduction with tamoxifen
- 1 November 1990
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 17 (1), 3-7
- https://doi.org/10.1007/bf01812678
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast painJournal of Endocrinology, 1988
- Coronary risk prediction in adults (The Framingham Heart Study)The American Journal of Cardiology, 1987
- Adjuvant Chemotherapy for Breast CancerPublished by American Medical Association (AMA) ,1985
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984
- Effects of an Antiestrogen on Subfractions of HDL Cholesterol during Estrogen Replacement TherapyGynecologic and Obstetric Investigation, 1984
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- Menopause and Coronary Heart DiseaseAnnals of Internal Medicine, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978